undefined undefined undefined

Cardiovascular and non-cardiovascular adverse events in patients with hematologic malignacies treated with BTK inhibitors: a real-world analysis

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Challenges when caring for cancer patients with heart disease

Access

Like

Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX

Event: ESC Congress 2024

Topic: Secondary Hypertension

Session: Secondary and resistant hypertension

Access

Like

SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Daily cardiac problems in cancer patients

Access

Like

Real-world analysis of transcatheter aortic valve replacement in patients with prostate cancer and severe aortic stenosis

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Cardiovascular complications in cardio-oncology: risk assessment

Access

Like

Coronary angioplasty or medical treatment in patients with aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real world analysis

Event: ESC Congress 2022

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation: the intangibles

Access

Like

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib or nilotinib: data from a large multinational collaborative network

Event: ESC Congress 2022

Topic: Cardio-Oncology

Session: Cardio-oncology 3

Access

Like

Long-term survival analysis of patients with heart failure of different etiologies in a brazilian cohort of outpatients - a bayesian approach

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure – epidemiology, prognosis, outcome

Access

Like

undefined undefined undefined

Contributor content

Cardiovascular and non-cardiovascular adverse events in patients with hematologic malignacies treated with BTK inhibitors: a real-world analysis

Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX

SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study

Real-world analysis of transcatheter aortic valve replacement in patients with prostate cancer and severe aortic stenosis

Coronary angioplasty or medical treatment in patients with aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real world analysis

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib or nilotinib: data from a large multinational collaborative network

Long-term survival analysis of patients with heart failure of different etiologies in a brazilian cohort of outpatients - a bayesian approach

ESC 365 is supported by